FDA approval expands earlier use of Enhertu for metastatic breast cancer
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
Frontiers22d
MRI-based intratumoral and peritumoral radiomics for assessing deep myometrial invasion in patients with early-stage endometrioid adenocarcinoma
Purpose: To evaluate the effectiveness of magnetic resonance imaging (MRI)-based intratumoral and peritumoral radiomics models for predicting deep myometrial invasion (DMI) of early-stage endometrioid ...
Medscape24d
Development of Targeted Therapy in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer
Endometrial cancer (EC) is the most common female genital malignancy in the USA. Most carcinomas arising from the uterus are estrogen dependent and are associated with obesity and hypertension ...
Frontiers28d
Contrast-enhanced ultrasound of collecting duct carcinoma in the renal: a case report misdiagnosed as renal abscess on computed tomography scan
Secondly, clear cell renal cell carcinoma (ccRCC) needed to be differentiated from CDC, ccRCC is the most common primary renal tumor. ccRCC has variable two-dimensional ultrasound echo patterns, often ...
The American Journal of Managed Care29d
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
Ovarian cancer incidence shows significant ... Also, they categorized the OC histology subtypes as serous carcinoma, endometrioid carcinoma, mucinous carcinoma, clear cell carcinoma ...